In line with these findings, we have recently shown that CAV1-deficient fibroblasts mediate radiation resistance of human prostate carcinoma cells in vitro and in vivo and that the decrease in cell death after radiation treatment is mediated though a paracrine mechanism of action [11]. Here, CAV1 is linked to prostate carcinoma.